Hospital Universitario Quironsalud Madrid — Clinical Trial Site

341 Registered trials

134 Currently recruiting

Organisation

Hospital Universitario Quironsalud Madrid

Location

Pozuelo De Alarcon, Spain

Identifier

ORG-100030938

Address

Calle De Diego De Velazquez 1, 28223, Spain

Departments

-
#2314:servicio de neurología
#2359: Servicio de dermatología
#2509: Servicio de oncología médica
#3304: Oncology
#3446: Endocrinología
#5400 :neurologia
034-01: Medical Oncology
03409: Oncology
1608:Oncología
2912: Hematology
3005:Reumatología
3301: Oncologia
34006: Oncology
5503: Neumología
7001: Oncology
7009: Oncology
7207: Neurology
724003: Oncology
9006: Neurology
Departamento de Neurología
Department of oncology
Department of Pediatrics
Dermatología
Dermatology
Dermatology department
Endocrinología
Endocrinology
Endocrinology and metabolism
Endocrinology and Nutrition
Endocrinology and Nutrition Service
Endrocrinology
Ginecología
Gynecologic Oncology
Haematology
Haematology and Hemotherapy
Hematología
Hematology
Hematology and Hemotherapy
Hematology and Hemotherapy Service
Hospital Universitario Quirón Salud Madrid
Hospital Universitario Quironsalud Madrid (#1)
Infectious Diseases
Medical Oncology
Medical Oncology Clinical Trial Unit
Medical Oncology Department
Medicina Interna
N/A
NA
Neonatología
Neonatology Department
Neumologia
Neumology
Neurología
Neurology
Neurology Department
NEXT Madrid - Oncology
NEXT Madrid Phase 1 trials
NEXT Madrid Phase I trials
Next Oncology
Next Oncology – Oncología médica
NEXT Oncology Madrid
NEXT Oncology Madrid – Hospital Universitario Quirónsalud Madrid
NEXT Oncology Madrid Phase I trials
NEXT Oncology Madrid Phase I Unit
NEXT Oncology Madrid. Phase I Unit
Obstetricia
Oncologia
Oncología Médica
Oncología Radioterápica
Oncology
Oncology Department
Oncology Service
Oncology trials department
Pain Unit
pediatria
Pediatrics
Phase 1 Clinical Trials Unit
Phase I Trials
Pneumology
Pneumology service
Pulmonology
Respiratory
Servicio de Dermatología
Servicio de Dermatología, planta -1
Servicio de Endocrinología
Servicio de Hematología
Servicio de Hematología y Hemoterapia
Servicio de Neumología
Servicio de Neurologia
Servicio de Oncologia
Servicio de Oncología Médica
Servicio Neumología
Servicio Oncología
Unidad de Ensayos Clínicos Fases I
Unidad de Reproducción Asistida Servicio de Obstetricia y Ginecologia
Unidad del Dolor
Unidad Fases I Next Oncology

Clinical trials at this site (341)

Search interface

A clinical study of V940 and BCG in people with bladder cancer (V940-011) Recruiting

2024-517335-46-00 Bladder cancer 4 2025-06-05
A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours Recruiting

2024-519184-18-00 Advanced Solid Tumour 7 2025-05-30
A clinical study of V940 and pembrolizumab to treat lung cancer (V940-009) Recruiting

2023-506327-29-00 Non-Small Cell Lung Cancer 5 2025-05-14
A Phase 2, Open-label, Randomized Study to Evaluate Prophylactic Interventions on Talquetamab-related Oral Toxicity Recruiting

2023-506260-14-00 multiple myeloma 4 2025-05-13
A trial to learn how well surovatamig (AZD0486) works and how safe it is in adults with certain blood cancers Recruiting

2023-505789-27-00 Relapsed or Refractory Non-Hodgkin Lymphoma 4 2025-04-14
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis Recruiting

2024-514845-12-00 Non-Cystic Fibrosis Bronchiectasis 4 2025-03-28
First -in-Human Study of DS-3939a in Subjects with Advanced Solid Tumors Recruiting

2023-507937-14-00 Metastatic Solid Tumor 7 2025-03-25
Phase I Study of PM54 Administered to Patients with Advanced Solid Tumors Recruiting

2024-517579-19-00 Selected Advanced Solid Tumors 3 2025-03-24
Ph 1 Study of ORIC-944 in Patients with Metastatic Prostate Cancer. Recruiting

2024-515527-11-00 Prostate cancer 1 2025-03-20
A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) an… Recruiting

2024-512900-20-00 Non-muscle invasive bladder cancer (NMIBC) 7 2025-01-30
Study of ORIC-114 in Patients with Advanced Solid Tumors Harboring an EGFR or HER2 Alteration Recruiting

2024-512264-66-00 Solid Tumors 7 2025-01-29
IKS03 in Advanced B cell NHL Recruiting

2024-512415-45-00 Advanced B cell Non-Hodgkin Lymphomas 3 2025-01-14
Phase 1, open-label, multicenter, dose escalation study of SRG-1505 as monotherapy in subjects with mature b-cell malignancies Recruiting

2023-505204-34-00 Mature B-Cell Neoplasm, Non-Hodgkin Lymphoma, Diffuse l 1 2024-12-30
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Subject… Recruiting

2024-513860-25-00 Ovarian Neoplasms 9 2024-12-10
A study to test long-term treatment with brigimadlin in people with solid tumours who took part in a previous study with this medicine Recruiting

2024-514177-21-00 Solid tumours 4 2024-12-02
A Study of ZL-1310 in Patients with Small Cell Lung Cancer to Find a Suitable Dose and to Test How Different Doses of ZL-1310 are Tolerated … Recruiting

2024-514446-36-00 Small Cell Lung Cancer 1 2024-11-21
A Phase IV, Multicenter, Open-label, Single-arm Study to Evaluate the Safety of Almagate in Pregnant Women With Heartburn and Reflux, and Pe… Recruiting

2024-515381-14-00 heartburn and or reflux 6 2024-11-20
Phase 1/2 study testing for the first time in humans a novel drug, STAR0602, to selectively stimulate T cells for the treatment of subjects … Recruiting

2023-505334-10-01 Unresectable, Locally Advanced, or Metastatic Solid Tum 7 2024-10-30
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants with Advanced Solid Malignancies Recruiting

2024-511453-22-00 Participants with Advanced Solid Malignancies 1 2024-10-28
Clinical trial comparing MK-2870 given with pembrolizumab to pembrolizumab alone in participants who have had surgery for NSCLC Recruiting

2023-508012-35-00 Newly diagnosed NSCLC with resectable clinical Stage II 5 2024-10-02
PErsonalized Addition of Recombinant LH in suboptimal responders >35 years old (POSEIDON group 2). A randomized controlled trial Recruiting

2024-514035-19-00 infertility 6 2024-09-23
A Window of Opportunity Trial To Learn If Linvoseltamab Is Safe And Well Tolerated, And How Well It Works In adult Participants With Recentl… Recruiting

2022-500800-24-00 Multiple Myeloma 4 2024-09-19
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting

2023-507353-15-00 idiopathic pulmonary fibrosis (IPF) 5 2024-09-10
A first-in-human study to investigate the safety and tolerability of a new antibody-guided drug delivery treatment for patients with therapy… Recruiting

2024-511074-80-01 Platinum-resistant high-grade ovarian cancer (PROC) or 7 2024-09-06